Nur77 exacerbates PC12 cellular injury in vitro by aggravating mitochondrial impairment and endoplasmic reticulum

Huimin Gao1, Zhaoyu Chen1, Yongmei Fu2

  • 1Department of Neurology, The Third Affiliated Hospital of Sun Yat-Sen University, Tianhe Road 600, Guangzhou, Guangdong 510630, P.R. China.

Scientific Reports
|September 30, 2016
PubMed

Insights

Nur77 activation worsens cell death by increasing mitochondrial impairment, ER stress, and autophagy. Nur77 may be a therapeutic target for Parkinson's disease (PD) and neurodegeneration.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • The nuclear orphan receptor Nur77 is implicated in neuroinflammation, apoptosis, and dopaminergic neurodegeneration.
  • Understanding Nur77's role in cell death mechanisms is crucial for neurodegenerative disease research.

Purpose of the Study:

  • To investigate the mechanisms by which Nur77 influences cell death in a cellular model of Parkinson's disease.
  • To explore the impact of Nur77 activation and knockdown on cellular injury.

Main Methods:

  • Utilized 6-hydroxydopamine (OHDA)-lesioned PC12 cells.
  • Administered Cytosporone B (Csn-B) as a Nur77 agonist and employed Nur77 knockdown.
  • Assessed cell viability, LDH release, intracellular calcium and ROS levels, apoptosis, ER stress, and mitochondrial function.

Main Results:

  • Nur77 activation led to its translocation to the cytosol and ER, co-localizing with Tom20 and PDI.
  • Activated Nur77 decreased cell viability, increased cellular damage markers (LDH, Ca2+, ROS), apoptosis, ER stress, and mitochondrial dysfunction (ΔΨm decline).
  • Nur77 activation enhanced autophagy, upregulated PINK1, and downregulated Parkin, with partial reversal by Nur77 knockdown.

Conclusions:

  • Nur77 activation exacerbates PC12 cell death by worsening mitochondrial impairment, ER stress, and enhancing autophagy.
  • Nur77 plays a significant role in mediating cellular injury in this model.
  • Nur77 represents a potential therapeutic target for Parkinson's disease (PD).